Following a rigorous regulatory process that ensures the best medicinal product is made available on the market in accordance with EU GMP standards, ASG Pharma was the first licensed company to be licenced to produce Medical Cannabis in Malta, followed by ZenPharm. A third company Materia Ltd. is in the process of obtaining its license and has already received its EU GMP certification. These licences ensure that patients are receiving products originating from the scientific advancements in medical cannabis which are of the highest quality, the most secure, and effective on the market.
The Malta Chamber welcomes this achievement which emerged from the setting up of the Business Section on Medical Cannabis within the Chamber a year ago. The Executive Committee was relentless in discussing opportunities and ways to optimise the licensing process to make the sector a true success and competitive enough globally, thus arriving at the opportunity of exporting a gold standard medicinal product produced locally and effectively contributing to Malta’s GDP growth.
Discussions were held regularly with Hon. Dr. Miriam Dalli, Minister for Energy, Enterprise and Sustainable Mobility, Mr. Kurt Farrugia, CEO Malta Enterprise, Hon. Deo Debattista, Parliamentary Secretary for Consumer Protection and Public Cleansing and most importantly with Prof. Anthony Serracino Inglott, Chairman of the Malta Medicines Authority together with all their respective teams in order to make this happen.
The Malta Chamber welcomes this ground-breaking achievement and the priority given to this sector to ensure its competitiveness worldwide.
